Nitrendipine

This page contains recent news articles, when available, and an overview of Nitrendipine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Nitrendipine
(when available)

Pharmacology and use:
Nitrendipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal's variant angina. Nitrendipine is similar to other peripheral vasodilators. Nitrendipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload. For the treatment of mild to moderate hypertension

Mechanism Of Action:
By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Nitrendipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

News Articles on Nitrendipine

Drug Delivery; Novel pH-dependent gradient-release drug delivery …  -  Feb 12, 2005
...a novel pH-dependent gradient-release drug delivery system for nitrendipine having a solid dispersed matrix structure" was devised by MS Yang and ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Shenyang Pharmaceutical University; Novel pH-dependent gradient- …  -  Feb 9, 2005
...a novel pH-dependent gradient-release drug delivery system for nitrendipine having a solid dispersed matrix structure" was devised by MS Yang and ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Eprosartan Lowers Blood Pressure, Reduces Risk of New Event After …  -  Feb 7, 2005
Nitrendipine in Secondary Prevention) included 1405 high-risk patients who had experienced at least 1 stroke or TIA over the past 24 months. ... DG News

TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac …  -  Nov 2, 2006
TTX (3 M) and nitrendipine (1 M) are included in the K + -free external solution. ... (E) Effects of SK&F96365 (SKF), nitrendipine (Nit), and xestospongin C ... Nature.com

Chronotherapy With Nifedipine GITS in Hypertensive Patients: Improved...  -  Mar 31, 2008
Thus, the effect of nitrendipine on the asleep BP mean was significantly greater when the daily dose was administered in the evening (at 6 PM) as compared ... Nature.com

Highlights of the 30th International Stroke Conference  -  Feb 28, 2005
Diener presented the initial results of the Morbidity and Mortality After Stroke - Eprosartan vs Nitrendipine for Secondary Prevention (MOSES) trial, ... Medscape

Short- and long-term discontinuation patterns of commonly prescribed ...  -  Mar 6, 2008
In the HANE (Hydrochlorothiazide, Atenolol, Nitrendipine and Enalapril) study, nitredipine (a CCB) was reported to have a higher rate of dropouts. ... Nature.com

Effect of Ca2(+)-channel agonists and antagonists on skeletal muscle ...  -  Jul 1, 2006
Nitrendipine was unable to reverse the changes in basal or insulin-mediated 3-MG transport caused by BAY K 8644. These results indicate that a low ... AJP-Regul Integr Comp Physiology...

Treating Systolic Hypertension  -  Aug 16, 2006
The Systolic Hypertension in Europe Study compared placebo with a calcium-channel blocking drug (nitrendipine) with an added ACE-inhibitor (enalapril) and ... HealthandAge.com

Verapamil-induced subacute cutaneous lupus erythematosus.(CASE …  -  Jul 1, 2005
A new calcium channel blocker, nitrendipine has also been reported to cause SCLE. (4) We believe that our case adds further support to a growing body of ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

Drug Delivery; Novel pH-dependent gradient-release drug delivery …  -  Feb 8, 2005
...a novel pH-dependent gradient-release drug delivery system for nitrendipine having a solid dispersed matrix structure" was devised by MS Yang and ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

Hypertension Therapy; Dihydropyridines have differential effects on …  -  Apr 23, 2005
..."Cilnidipine, felodipine, nifedipine, nilvadipine, nimodipine, and nitrendipine had little effect on the T-type channel," test results indicated. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Revue : le contrôle rigoureux de la pression artérielle et le...  -  Nov 25, 2006
Exception faite de ceux de la nitrendipine, les effets indésirables des différents traitements ont été comparables. Le contrôle rigoureux de la pression ... EBM Journal (Abonnement)

Hypertension Therapy; Dihydropyridines have differential effects on …  -  Apr 18, 2005
..."Cilnidipine, felodipine, nifedipine, nilvadipine, nimodipine, and nitrendipine had little effect on the T-type channel," test results indicated. ... Pay-Per-View - Cardiovascular Week - Factiva, from Dow Jones

Teikyo University; Dihydropyridines have differential effects on...  -  Apr 20, 2005
..."Cilnidipine, felodipine, nifedipine, nilvadipine, nimodipine, and nitrendipine had little effect on the T-type channel," test results indicated. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Calcineurin-inhibitor induced pain syndrome after organ transplantatio...  -  Sep 6, 2006
The use of calcium antagonists (preferably nifedipine or nitrendipine), which do not inhibit the cytochrome P450, seems to be equally useful in reducing ... Nature.com

Cannabidiol, unlike synthetic cannabinoids, triggers activation of...  -  Feb 5, 2007
...sensitive to clotrimazole and nitrendipine (10-30 µM). This action, although mimicked by 9 -tetrahydrocannabinol (THC), is opposite to that inhibitory, ... Journal of Leukocyte Biology (subscripti...

Up4A stimulates endothelium-independent contraction of isolated rat …  -  Sep 27, 2007
Up 4 A-induced contraction was also inhibited by pretreatment with thapsigargin, nitrendipine, or EGTA but unaffected by H1152. Furthermore, unlike ATP and ... AJP-Lung Physiology (subscription)

Handling difficult samples in bio-analytical chemical analysis  -  Jun 1, 2008
Nifedipine, nitrendipine and nimodipine are dihydropyridine calcium antagonists that are prone to photo-oxidation degradation. Nifedipine has a half life of ... Pharmaceutical Technology Europe

JournalWatch: Low BP no problem in old.(blood pressure)(Brief...  -  Oct 3, 2007
The active treatment arm involved treatment with nitrendipine - a calcium channel blocker - which could be combined with or replaced by enalapril or ... Free with registration - Pulse - AccessMyLibrary.com

The Benefits and Strategies for Treating Elderly Hypertensive Patients  -  Sep 23, 2008
...which reported the biggest effect of antihypertensive therapy on dementia to date, treatment was based on a calcium channel blocker [CCB], nitrendipine, ... Medscape

Activation of L-Type Calcium Channels Induces Corticotropin-Releasing...  -  Mar 15, 2007
Furthermore, the KCl-induced CRF secretion involved L-type calcium channels activation, as 2 µmol/L nitrendipine, an L-type specific blocker, abolished the ... Journal of Clinical Endocrinology and...

Running, jumping increase back pain.(SPORTS)(WEEKEND ATHLETE: …  -  Dec 24, 2006
The following drugs should not be taken with grapefruit juice: calcium channel blockers such as felodipine, nitrendipine, nisoldipine, nifedipine, ... $4.95 - Washington Times - ECNext

Effect of short-term organoid culture on the pharmaco-mechanical …  -  May 26, 2005
...potential (high-potassium solutions – levcromakalim, a potassium channel opener), while nitrendipine, an L-type calcium channel blocker, suppressed SRC. ... Nature.com

PRoFESS published: Perseverance may pay with telmisartan in recurrent...  -  Aug 28, 2008
...such as MOSES (Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention) and HOPE (Heart Outcomes Prevention ... Medwire (subscription)

Lowering Blood Pressure Doesn't Prevent Cognitive Impairment, …  -  May 24, 2006
One blood-pressure medication, Nitrendipine, did appear to reduce dementia in one of the studies reviewed, but when combined with all data, this effect was ... Medical News Today - Medical News Today (press release)

National Institutes of Health, US Researchers from National Institutes...  -  Jan 8, 2007
Furthermore, [3H] nitrendipine and bodipy-F1-dihydropyridine accumulation assays showed that these compounds are transported by ABCG2," the scientists ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Antihypertensives demonstrate benefit in reducing Alzheimer's disease...  -  Jul 1, 2006
Taking into account that the Systolic Hypertension in Europe (Syst-Eur) trial had illustrated the protective benefits of nitrendipine, the researchers ... Free with registration - Formulary - AccessMyLibrary.com

ReNeuron Group plc - AGM Statement.  -  Sep 21, 2006
MOSES (Morbidity and mortality after stroke - Eprosartan vs nitrendipine for secondary prevention) study, Feb 2006 2. American Heart Association, Reporting ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Potassium-sparing diuretics  -  Mar 24, 2006
This could have been due to small sample size, said Zandi, who added that the trend supports the Syst-Eur finding of a protective effect with nitrendipine. ... Medscape

Dementia Not Prevented in Older People by Lowering Blood Pressure  -  May 25, 2006
One blood-pressure medication, Nitrendipine, did appear to reduce dementia in one of the studies reviewed, but when combined with all data, this effect was ... SeniorJournal.com

Lowering blood pressure does not appear to prevent cognitive or …  -  May 29, 2006
One blood-pressure medication, Nitrendipine, did appear to reduce dementia in one of the studies reviewed, but when combined with all data, this effect was ... News-Medical.net

Loyola University; Findings in diabetic nephropathy provide new...  -  Feb 16, 2005
...or methoxamine were determined before and after administration of nitrendipine (Nit), 5-methylurapidil (5-MeU), chloroethylclonidine (CEC), ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

ReNeuron Group plc - Exercise of Warrants.  -  Nov 15, 2006
MOSES (Morbidity and mortality after stroke - Eprosartan vs nitrendipine for secondary prevention) study, Feb 2006 2. American Heart Association, Reporting ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Aggressive hypertension management in patients of advancing and …  -  Aug 1, 2005
These trials utilized the long-acting calcium channel blocker nitrendipine and included the potential addition of an angiotensin-converting enzyme inhibitor ... $4.95 - Southern Medical Journal - ECNext

Diabetic Nephropathy; Findings in diabetic nephropathy provide new …  -  Feb 19, 2005
...or methoxamine were determined before and after administration of nitrendipine (Nit), 5-methylurapidil (5-MeU), chloroethylclonidine (CEC), ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Diabetic Nephropathy; Findings in diabetic nephropathy provide new …  -  Feb 14, 2005
...or methoxamine were determined before and after administration of nitrendipine (Nit), 5-methylurapidil (5-MeU), chloroethylclonidine (CEC), ... Pay-Per-View - Diabetes Week - Factiva, from Dow Jones

Article: Effectiveness of Grapefruit Diet Studied at Vanderbilt...  -  May 11, 2006
...interferes with a vital ... should not be taken with grapefruit juice include: Nimodipine, Nitrendipine ... should not be taken with grapefruit juice. ... Pay-Per-View - AScribe Health News Service - HighBeam Research

National Institutes of Health, US Scientists from National Institutes...  -  Dec 11, 2006
Furthermore, [3H] nitrendipine and bodipy-F1-dihydropyridine accumulation assays showed that these compounds are transported by ABCG2," the scientists ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Hoge bloeddruk  -  Nov 15, 2005
...barnidipine, diltiazem, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine met vertraagde afgifte, nitrendipine en verapamil. ... kiesbeter.nl

NU IN DE WINKEL  -  Jul 1, 2006
Nifedipine, Nicardipine en Nitrendipine kunnen na de instapperiode wel goed gebruikt worden. Ook middelen als Felodipine, Amlodipine en Isradipine kunnen ... Duiken

아서틸 중심으로 본 ASCOT-BPLA  -  Mar 30, 2006
...셋째로 뉴 드러그 중 어떤 것� 좋�가� 대해서는MOSES(Morbidity and mortality after Stroke Eprosartan vs nitrendipine for Secondary prevention) 연구�서 ... 메디칼트리뷴

Éditorial - Découvrir EBM Journal  -  May 12, 2006
Les études Syst-Eur, où le traitement est initié par la nitrendipine, CAPPP où le captopril fait au moins jeu égal avec le traitement conventionnel, ... EBM Journal (Abonnement)

Brand Names/Synonyms:
Nitrendipine is also known by the following brand names and/or synonymsBay E 5009; Bay-E 5009; Bayotensin; Baypress; Bylotensin; CA-212; CHEMBANK117; Deiten; N144; Nidrel; Nitrendipin; Nitrendipine; Nitrendipine [Usan:Ban:Inn:Jan]; Nitrendipine, Pharma; Nitrendipino [Inn-Spanish]; Nitrendipinum [Inn-Latin]; Nitrepin

Drug Category:
Nitrendipine is categorized under the following by the FDA: Vasodilator Agents; Antihypertensive Agents; ATC:C08CA08; Calcium Channel Blockers;

Dosage Forms:
Not Available

Absorption:
Not Available

Interactions:
Not Available



Chemical IUPAC Name:
methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy